首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Ardisia crispa root hexane fraction suppressed angiogenesis in human umbilical vein endothelial cells (HUVECs) and in vivo zebrafish embryo model
【24h】

Ardisia crispa root hexane fraction suppressed angiogenesis in human umbilical vein endothelial cells (HUVECs) and in vivo zebrafish embryo model

机译:Ardisia Crispa根己烷级分抑制人脐静脉内皮细胞(Huvecs)和体内斑马鱼胚胎模型中的血管生成

获取原文
获取原文并翻译 | 示例
           

摘要

Ardisia crispa Thunb. A. DC. (Primulaceae) has been used extensively as folk-lore medicine in South East Asia including China and Japan to treat various inflammatory related diseases. Ardisia crispa root hexane fraction (ACRH) has been thoroughly studied by our group and it has been shown to exhibit anti-inflammatory, anti-hyperalgesic, anti-arthritic, anti-ulcer, chemoprevention and suppression against inflammation-induced angiogenesis in various animal model. Nevertheless, its effect against human endothelial cells in vitro has not been reported yet. Hence, the aim of the study is to investigate the potential antiangiogenic property of ACRH in human umbilical vein endothelial cells (HUVECs) and zebrafish embryo model. ACRH was separated from the crude ethanolic extract of the plant's root in prior to experimental studies. MTT assay revealed that ACRH exerted a concentration-dependent anti-proliferative effect on HUVEC with the IC50 of 2.49 +/- 0.04 mu g/mL. At higher concentration (10 mu g/mL), apoptosis was induced without affecting the cell cycle distribution. Angiogenic properties including migration, invasion and differentiation of HUVECs, evaluated via wound healing, trans-well invasion and tube formation assay respectively, were significantly suppressed by ACRH in a concentration-dependent manner. Noteworthily, significant anti-angiogenic effects were observed even at the lowest concentration used (0.1 mu g/mL). Expression of proMMP-2, vascular endothelial growth factor (VEGF)-C, VEGF-D, Angiopoietin-2, fibroblast growth factor (FGF)-1, FGF-2, Follistatin, and hepatocyte growth factor (HGF) were significantly reduced in various degrees by ACRH. The ISV formation in zebrafish embryo was significantly suppressed by ACRH at the concentration of 5 mu g/mL. These findings revealed the potential of ACRH as anti-angiogenic agent by suppressing multiple proangiogenic proteins. Thus, it can be further verified via the transcription of these proteins from their respective DNA, in elucidating their exact pathways.
机译:ardisia crispa thunb。 A. DC。 (Primulaceae)已被广泛用作东南亚民间轻动医药,包括中国和日本治疗各种炎症相关疾病。我们的小组已经彻底研究了Ardisia Crispa Root己烷份数(ACRH),并且已被证明表现出抗炎,抗痛苦,抗关节炎,抗溃疡,化学预防和对各种动物模型中炎症诱导的血管生成的抑制。然而,尚未报告其对体外人类内皮细胞的影响。因此,该研究的目的是探讨人脐静脉内皮细胞(HUVECS)和斑马鱼胚胎模型中ACRH的潜在抗血管性能。在实验研究之前,acrah与植物根的粗乙醇提取物分开。 MTT测定显示,ACRH对HUVEC的浓度依赖性抗增殖作用,IC50为2.49 +/-0.04μg/ mL。在较高浓度(10μg/ ml),诱导细胞凋亡而不影响细胞周期分布。通过伤口愈合,反式阱侵袭和管形成测定分别评估的Huvecs的血管生成性能,通过伤口愈合,反式阱侵袭和管形成测定,acrh以浓度依赖性方式显着抑制。值得注意的是,即使在使用的最低浓度(0.1μg/ ml),也观察到显着的抗血管生成效果。显着减少了显着降低了PROMMP-2,血管内皮生长因子(VEGF)-C,VEGF-D,血管生成素-2,成纤维细胞生长因子(FGF)-1,FGF-2,FOLLISTATIN和肝细胞生长因子(HGF) acrh各种程度。斑马鱼胚胎中的ISV形成受到5μg/ ml浓度的acrh显着抑制。这些发现通过抑制多种常规蛋白,揭示了Acrh作为抗血管生成剂的潜力。因此,可以通过从它们各自的DNA转录来进一步验证它们各自的DNA,阐明它们的确切途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号